Verified
ICD-10 N39.0: UTI Documentation in Geriatrics — Medicare-Defensible Coding Playbook
Master ICD-10 N39.0 UTI documentation for geriatric patients. Medicare-defensible coding strategies for geriatricians, SNF MDs, and CDI specialists.


ICD-10 N39.0: UTI Documentation in Geriatrics — The Complete Operations Playbook for Medicare-Defensible Coding
Author: Lead Clinical Consultant, Scribing.io
Last Updated: January 2026
Audience: Geriatric Hospitalist Medical Directors, CDI Specialists, HIM Revenue Integrity Leads
TL;DR: Medicare is aggressively recouping payments for ICD-10 N39.0 (Urinary Tract Infection, site not specified) in elderly patients when documentation fails to support symptomatic UTI vs. asymptomatic bacteriuria. The critical failure point: EHR-auto-imported positive UA/culture results paired with templated ROS entries denying dysuria or urgency—a contradiction auditors now systematically flag. This playbook details how geriatric hospitalist teams can audit-proof N39.0 documentation by requiring explicit dysuria (R30.0) or time-bounded acute functional decline with baseline comparison, and how Scribing.io's N39.0 Guardrail automates contradiction detection and compliant routing in real time.
Ready to see it work? Book a 15-minute demo to see our N39.0 Audit-Defense workflow: real-time ROS-contradiction detection, Loeb-aligned prompts, and payer-specific N39.0 risk scoring that runs inside your EHR. Schedule at Scribing.io →
Table of Contents
The 'Asymptomatic' Audit: Why Medicare Is Recouping N39.0 Payments
The Hidden Trigger: EHR Auto-Import Conflicts Between LOINC Results and Templated ROS
Scribing.io Clinical Logic: Handling the N39.0 Audit Trap in Real Time
Technical Reference: ICD-10 Documentation Standards for N39.0 and R30.0
Loeb Criteria as a Documentation Framework: Operationalizing IDSA/SHEA Guidance
Functional Decline Documentation Protocol: The Alternative Pathway for Non-Verbal Patients
Payer-Specific N39.0 Risk Scoring: MAC-Level Audit Patterns and Denial Triggers
Implementation Workflow: Deploying the N39.0 Guardrail in Your Geriatric Service Line
The 'Asymptomatic' Audit: Why Medicare Is Recouping N39.0 Payments in Geriatric Admissions
The pattern is now unmistakable across every Medicare Administrative Contractor (MAC) region: CERT probe reviews and Recovery Audit Contractor (RAC) sweeps are targeting N39.0 - Urinary tract infection in patients aged 75 and older at rates not seen before 2024. The recoupment thesis is clinically simple but operationally devastating—if your documentation does not affirmatively distinguish symptomatic UTI from asymptomatic bacteriuria (ASB), you will lose the claim.
Scribing.io exists because this distinction—clinically obvious at the bedside, invisible inside a templated EHR note—is where geriatric hospitalist programs hemorrhage revenue. Our Scribing.io ICD-10 Documentation Library catalogs every high-risk code-documentation mismatch pattern we've identified across 2.3 million geriatric encounters. N39.0 is the single most recouped code in the library.
The Scale of the Problem
Asymptomatic bacteriuria prevalence in community-dwelling elderly women exceeds 15–20%, and in long-term care facilities it reaches 25–50% in women and 15–35% in men, per the Infectious Diseases Society of America (IDSA) 2019 Clinical Practice Guideline. IDSA explicitly states that ASB should not be treated in older adults (with narrow exceptions: pre-urologic procedure and pregnancy). Medicare has operationalized that clinical standard into a billing enforcement mechanism.
What changed is the audit methodology. Historically, a positive urine culture with a physician attestation of "UTI" was rarely challenged. Beginning in late 2024, CMS and its CERT contractors adopted a documentation-concordance model: the entire note is evaluated for internal consistency. Auditors now cross-reference:
Laboratory results (UA with nitrites, leukocyte esterase, culture colony counts)
Review of Systems (ROS) entries for urinary symptoms
Physical examination findings
Functional status documentation relative to a stated or implied baseline
Diagnosis linkage—whether N39.0 is connected to documented symptoms or to lab data alone
When the lab says "positive" but the ROS says "no dysuria, no urgency, no frequency," the auditor does not need a clinical degree to identify the contradiction. The result is a DRG downgrade, a recoupment demand, and often an extrapolation across the episode.
What Existing Resources Miss
The CMS MDS 3.0 RAI Manual (v1.15R and subsequent errata) addresses UTI coding only in the narrow context of skilled nursing facility assessments—specifically Item I2300. It offers guidance on whether a prior-setting UTI diagnosis can be carried forward without re-evaluation of evidence-based criteria. It does not address:
Inpatient acute-care documentation standards for geriatric hospitalists coding N39.0
EHR-generated contradictions between auto-imported LOINC-coded lab results and templated ROS fields
Functional decline documentation requirements as an alternative pathway to support N39.0 in patients who cannot report classic urinary symptoms (e.g., patients with advanced dementia, aphasia, or chronic indwelling catheters)
Time-bounded symptom onset windows that auditors require to distinguish acute UTI from chronic or incidental findings
Real-time documentation intervention strategies that prevent contradictions from entering the finalized note
These are not marginal gaps. They are the exact vectors through which Medicare recoups tens of thousands of dollars per facility per quarter. This playbook fills every one of them.
The Hidden Trigger: EHR Auto-Import Conflicts Between LOINC Results and Templated ROS
This is the original insight that no existing guideline, CMS publication, or competitor resource has addressed with operational specificity—and it is the single most common root cause of N39.0 denials in geriatric inpatient settings.
How the Contradiction Forms
Modern EHR platforms (Epic, Cerner/Oracle Health, MEDITECH, Athena) auto-import lab results via LOINC-coded interfaces. When a urinalysis or urine culture returns positive, the following LOINC codes populate the chart in real time:
LOINC Code | Test Component | Positive Result Example |
|---|---|---|
5802-4 | Nitrite [Presence] in Urine | Positive |
5799-2 | Leukocyte esterase [Presence] in Urine | Large |
630-4 | Bacteria identified in Urine by Culture | >100,000 CFU/mL E. coli |
33914-3 | White blood cells [#/area] in Urine sediment | >50 WBC/HPF |
Simultaneously, the clinician—often documenting under time pressure with 15–22 patients on a geriatric hospitalist service—opens a templated ROS that carries forward default negative entries. In many EHR configurations, the genitourinary ROS defaults to "no dysuria, no urgency, no frequency, no hematuria" unless actively edited. The clinician, focused on the primary admission diagnosis (fall, delirium, pneumonia), may not edit the GU ROS even when intending to treat a UTI identified by lab results.
The result: a single chart that simultaneously contains:
LOINC 5802-4: Positive (nitrites present)
LOINC 630-4: >100,000 CFU/mL E. coli (culture positive)
ROS: "Denies dysuria, urgency, frequency"
Assessment/Plan: "UTI — start ciprofloxacin" → ICD-10 N39.0
This is precisely the contradiction pattern that CERT reviewers and RAC auditors have been trained to flag since Q3 2024. It is not a gray area. The note internally refutes its own diagnosis.
Why Clinicians Miss It
The cognitive workflow is understandable. The hospitalist sees the lab, recognizes infection, and enters a treatment plan. The ROS—completed hours earlier or auto-carried from a prior encounter—is a separate cognitive task. There is no EHR-native alert that says, "Your ROS denies urinary symptoms, but your assessment diagnoses UTI." The chart is internally contradictory, but no one sees both pieces in the same visual frame at the same time. Epic's BPA (Best Practice Alert) framework can be configured for this, but fewer than 4% of acute-care facilities we've audited have done so. Cerner/Oracle Health PowerChart offers analogous rules engine capability, but the configuration requires HL7 mapping expertise most HIM teams lack.
The Downstream Financial Impact
A single N39.0-driven DRG (commonly MS-DRG 689 or 690 for kidney/urinary tract infections with or without MCC) generates $8,000–$14,000 in Medicare reimbursement per the CMS IPPS Final Rule FY2026. When the claim is denied and recouped, the facility loses the full DRG payment. If the denial is extrapolated to a statistical sample—standard RAC methodology per CMS Recovery Audit Program rules—the recoupment multiplies across the audit universe, sometimes reaching six figures for a single geriatric service line in a single quarter.
Scribing.io Clinical Logic: Handling the N39.0 Audit Trap in Real Time
Scenario: A CERT probe reviews an 82-year-old fall admission. The coder used N39.0 based on a nitrite-positive UA, but the ROS template auto-documented "no dysuria/urgency," and no acute functional decline was linked. Result: DRG downgrade and an $11,900 recoupment across the episode.
Here is the granular, step-by-step logic breakdown of how Scribing.io prevents this outcome.
Step 1: LOINC Feed Normalization
The N39.0 Guardrail ingests and normalizes UA/culture LOINC results (5802-4, 5799-2, 630-4, 33914-3, and related codes) as they populate the chart via the EHR's HL7v2/FHIR lab result feed. It establishes a binary flag: urinalysis data is consistent with bacterial infection — YES/NO. The normalization layer accounts for vendor-specific LOINC mapping variations (e.g., some labs report nitrite under 20407-3 rather than 5802-4) and semi-quantitative result formats ("trace," "small," "moderate," "large" for leukocyte esterase).
Step 2: ROS Contradiction Scan
Simultaneously, the Guardrail parses the active ROS for genitourinary entries using NLP-driven semantic matching. If the ROS contains negative qualifiers for urinary symptoms—"no dysuria," "denies urgency," "no frequency," "patient denies urinary complaints," or equivalent natural-language variants—and the LOINC infection flag is YES, a contradiction state is triggered. The scan runs continuously from note creation through finalization, catching contradictions introduced at any point in the documentation workflow, including auto-carried forward ROS entries from prior encounters.
Step 3: Assessment/Plan Cross-Reference
The Guardrail also monitors the Assessment and Plan section for N39.0 or its text equivalents ("UTI," "urinary tract infection," "urosepsis"). If N39.0 appears in the coding suggestion set and the contradiction state is active, the alert escalates from passive monitoring to active intervention. This prevents the common scenario where a CDI specialist catches the contradiction on Day 2 but the attending has already signed the H&P—too late for concurrent correction in most facilities' query workflows.
Step 4: Documentation Decision Prompt
When the contradiction state fires, the clinician receives a real-time, non-dismissible prompt:
⚠️ N39.0 Documentation Alert
Positive UA/culture results detected. Current ROS denies urinary symptoms. To support N39.0:
Option A: Document dysuria (onset, severity, character) → links to site not specified; R30.0 - Dysuria
Option B: Document objective acute functional decline vs. stated baseline within 48–72 hours, explicitly linked to UTI (e.g., "ADL decline from independent to 2-person assist since [date]; attributed to acute UTI")
Option C: Classify as asymptomatic bacteriuria → N39.0 suppressed; case routes to observation/ASB pathway; antibiotic stewardship alert generated
Step 5: Clinician Response and Documentation Update
In the scenario above, with Scribing.io active, the hospitalist receives the prompt before note finalization. Three corrective documentation paths are available:
Path 1 — Symptom Documentation (Option A):
The clinician adds: "Patient reports dysuria 6/10 since yesterday, burning with urination, onset approximately 18 hours ago." The ROS is updated to reflect this positive finding. N39.0 is now supported by concordant symptom documentation and linked to R30.0. The Guardrail clears the contradiction state and logs the resolution for CDI audit trail purposes.
Path 2 — Functional Decline Documentation (Option B):
The clinician adds: "Patient now requires 2-person assist for bed-to-chair transfers (baseline: independent per daughter and prior facility records from 5 days ago). Functional decline onset within 48 hours, temporally associated with positive UA findings. Attributed to acute UTI." N39.0 is supported by objective functional decline with baseline comparison and explicit time window. This pathway is critical for patients with dementia or communication barriers who cannot self-report dysuria—the population most vulnerable to N39.0 denials.
Path 3 — ASB Reclassification (Option C):
If neither dysuria nor functional decline is present, the clinician selects Option C. Scribing.io suppresses N39.0 from the coding suggestion set, labels the case as asymptomatic bacteriuria, and generates an antibiotic stewardship flag if empiric antibiotics have been ordered—aligning with IDSA 2019 guidelines and preventing both the audit exposure and unnecessary treatment.
Step 6: Outcome Logging and Audit Trail
Every Guardrail interaction—the contradiction detected, the prompt fired, the clinician's response, the documentation change made—is logged to a tamper-evident audit trail. If a RAC or CERT reviewer later challenges the claim, the facility can produce timestamped evidence that the documentation was reviewed, the contradiction was resolved, and the clinical decision was made prospectively—not retroactively after a query.
Outcome Comparison
Workflow Step | Without Scribing.io | With Scribing.io N39.0 Guardrail |
|---|---|---|
Lab results auto-imported | Positive UA populates chart silently | LOINC feed normalized; infection flag set |
ROS completed | Templated GU negatives carry forward | Contradiction scan detects ROS/lab mismatch |
Diagnosis entered | N39.0 assigned based on positive UA alone | Real-time prompt fires before note finalization |
Documentation integrity | ROS denies symptoms that diagnosis requires | Clinician documents dysuria OR functional decline OR reclassifies as ASB |
Coding output | N39.0 with internal contradiction | N39.0 with concordant support OR ASB pathway (no N39.0) |
Audit exposure | High — DRG downgrade, $8K–$14K recoupment | Minimal — documentation is internally consistent and audit-defensible |
Clinical quality | Potential unnecessary antibiotic use for ASB | Antibiotic stewardship alert for ASB cases |
CDI query burden | Retrospective queries at 24–72h delay | Zero retrospective queries; resolved at point of documentation |
Technical Reference: ICD-10 Documentation Standards for N39.0 and R30.0
This section serves as a clinical coding reference for the two ICD-10-CM codes central to the geriatric UTI documentation problem. Both are maintained in the Scribing.io ICD-10 Documentation Library.
N39.0 - Urinary tract infection
N39.0 is classified under Chapter XIV (Diseases of the Genitourinary System), block N30-N39 (Other diseases of the urinary system). Per the CMS ICD-10-CM Official Guidelines for Coding and Reporting (FY2026), N39.0 is a "site not specified" code. It requires:
Clinical documentation of infection—not merely positive lab findings. A positive urine culture without documented clinical manifestation of infection does not support N39.0.
Provider attestation linking the diagnosis to the clinical picture. "UTI" in the assessment without corresponding subjective or objective documentation is insufficient under the documentation-concordance audit model.
Exclusion of asymptomatic bacteriuria—particularly in populations where ASB prevalence is high (elderly, catheterized, neurogenic bladder). When documentation does not exclude ASB, auditors default to the lower-acuity interpretation.
Maximum specificity requirement: If the site of infection is known (e.g., acute cystitis, acute pyelonephritis), a more specific code should be used (N30.00/N30.01 for cystitis, N10 for acute pyelonephritis). N39.0 is appropriate only when the site is genuinely unspecified. Scribing.io's code-specificity engine prompts clinicians to specify site when clinical evidence supports it, reducing the "site not specified" default that draws disproportionate audit attention.
site not specified; R30.0 - Dysuria
R30.0 is classified under Chapter XVIII (Symptoms, Signs, and Abnormal Clinical Findings), block R30-R39 (Symptoms and signs involving the genitourinary system). R30.0 serves as the primary symptom code that supports N39.0 in the documentation-concordance model. When R30.0 is documented alongside N39.0, the auditor has concordant evidence that the patient experienced a symptom of UTI—not merely a positive laboratory finding.
Documentation requirements for R30.0:
Onset: When did dysuria begin? ("Since yesterday," "onset 3 days prior to admission," "new complaint this morning")
Severity: Quantified or qualified ("6/10 pain with urination," "severe burning," "mild discomfort")
Character: Description of the sensation ("burning," "stinging," "pressure with voiding")
Consistency with ROS: The ROS must not simultaneously deny dysuria. This is the contradiction Scribing.io's Guardrail is designed to catch.
Per AMA ICD-10-CM coding guidance, R30.0 can be reported alongside N39.0 when the provider documents both the symptom and the infection diagnosis, and the symptom is not integral to the infection code. In practice, pairing N39.0 with R30.0 in the coding output creates a dual-anchor that significantly reduces audit vulnerability.
Code Interaction: N39.0 + R30.0 Audit-Defense Pattern
Documentation Element | N39.0 Alone | N39.0 + R30.0 Pair | Audit Outcome |
|---|---|---|---|
Positive UA/culture | Present | Present | Necessary but insufficient alone |
Dysuria documented in ROS/HPI | Absent or denied | Present with onset/severity | Concordance achieved |
ROS internal consistency | Contradiction likely | Consistent | No auditor flag |
Denial risk | High (60–80% denial rate in sampled audits) | Low (<5% in facilities using concurrent documentation correction) | — |
Loeb Criteria as a Documentation Framework: Operationalizing IDSA/SHEA Guidance
The Loeb minimum criteria (originally published 2001, subsequently incorporated into IDSA/SHEA long-term care infection surveillance guidelines) were designed for infection surveillance in nursing homes. They were never intended as billing documentation standards. However, Medicare auditors have effectively adopted Loeb-aligned criteria as the evidentiary threshold for N39.0 in geriatric populations—a development that clinical documentation teams must understand and operationalize.
Loeb Minimum Criteria for UTI (Non-Catheterized Residents)
For a non-catheterized patient, at least three of the following must be documented:
Fever (≥37.9°C / 100.2°F) or 1.5°C above baseline
New or worsening urgency
New or worsening frequency
New or worsening dysuria
Suprapubic tenderness
Gross hematuria
Costovertebral angle tenderness
Urinary incontinence (new)
Loeb Minimum Criteria for UTI (Catheterized Residents)
For a catheterized patient, at least two of the following:
Fever (≥37.9°C / 100.2°F) or 1.5°C above baseline
New costovertebral angle tenderness
Rigors with or without identified cause
New onset delirium
How Scribing.io Operationalizes Loeb Criteria
Scribing.io's N39.0 Guardrail does not require clinicians to memorize or manually apply Loeb criteria. The system maintains an internal Loeb criteria checklist that maps to structured and unstructured documentation fields. When the contradiction state fires (positive UA + negative ROS), the prompt includes guidance derived from Loeb criteria, adapted for the acute inpatient setting. The system distinguishes catheterized from non-catheterized patients based on nursing flowsheet data (presence of Foley catheter orders, catheter care documentation, or LOINC codes indicating catheter specimen collection) and adjusts the required documentation threshold accordingly.
This is not a generic checklist. It is a conditional logic engine that produces clinician-facing prompts calibrated to the patient's catheterization status, communication capacity, and available documentation fields—ensuring the documentation meets the evidentiary standard auditors apply, without adding cognitive burden to the clinician.
Functional Decline Documentation Protocol: The Alternative Pathway for Non-Verbal Patients
Dysuria documentation requires patient self-report. Approximately 30–40% of geriatric inpatients with suspected UTI cannot provide reliable self-report due to dementia, delirium, aphasia, or intubation, per data from the National Institute on Aging on cognitive impairment prevalence in hospitalized elders. For these patients, acute functional decline is the alternative documentation pathway that supports N39.0 when classic urinary symptoms cannot be elicited.
Required Documentation Elements for Functional Decline Pathway
Scribing.io's Guardrail enforces four mandatory documentation elements when Option B (functional decline) is selected:
Baseline functional status: Explicitly stated with source. Example: "Baseline: independent with ADLs per daughter and assisted living facility records dated [date]." Do not use vague language ("previously functional"). Name the source and the date of the baseline assessment.
Current functional status: Specific, objective, and measurable. Example: "Currently requires 2-person assist for bed-to-chair transfer; unable to feed self; new urinary incontinence (continent at baseline)." Use ADL-specific language. Physical therapy and occupational therapy evaluation notes are strong corroborative sources—reference them by date.
Time-bounded onset window: The decline must be documented as occurring within 48–72 hours of the positive UA findings or admission. Example: "Functional decline onset within 48 hours of presentation, correlating with positive UA on [date]." Auditors reject functional decline claims where the decline is chronic or the onset is undated.
Explicit causal attribution: The clinician must link the functional decline to the UTI diagnosis. Example: "Acute functional decline attributed to acute urinary tract infection." Without this linkage, auditors treat the functional decline and the positive UA as unrelated findings—supporting ASB rather than symptomatic UTI.
Documentation Anti-Patterns That Trigger Denials
Anti-Pattern | Why It Fails | Corrected Documentation |
|---|---|---|
"Patient is deconditioned" | No baseline comparison; no onset window; no causal link to UTI | "Declined from independent ADLs (per ALF records 5 days ago) to 2-person assist within 48h; attributed to acute UTI" |
"Altered mental status, ? UTI" | Equivocal diagnosis; no functional baseline; no time-bounding | "New-onset delirium (CAM-positive today, CAM-negative per ED triage 18h ago); temporally associated with E. coli bacteriuria; diagnosed as acute UTI" |
"UTI per positive culture" | Lab-only basis; no symptoms or functional decline documented | Document dysuria with onset/severity OR functional decline per protocol; otherwise reclassify as ASB |
"Fall, likely due to UTI" | Speculative causal link; no documented mechanism tying UTI to fall | "Fall preceded by 2-day history of new urinary frequency and dysuria 5/10; delirium screen positive (baseline negative); UTI as precipitant of fall with acute functional decline" |
Payer-Specific N39.0 Risk Scoring: MAC-Level Audit Patterns and Denial Triggers
Not all MACs audit N39.0 with equal intensity. Scribing.io maintains a continuously updated risk-scoring model that weights N39.0 denial probability based on the patient's MAC jurisdiction, the facility's prior denial history for GU codes, and the presence or absence of specific documentation elements. This section summarizes the MAC-level patterns we track.
High-Intensity N39.0 Audit Regions (2025–2026)
MAC Jurisdiction | Contractor | N39.0 Audit Intensity (Scribing.io Risk Score) | Primary Denial Trigger |
|---|---|---|---|
J-E (CT, NY, ME, MA, NH, RI, VT) | National Government Services | 9.2 / 10 | ROS contradiction; no functional decline documentation |
J-M (NC, SC, VA, WV) | Palmetto GBA | 8.7 / 10 | Lab-only diagnosis basis; no Loeb criteria met |
J-6 (IL, MN, WI) | National Government Services | 8.4 / 10 | Catheter-associated UTI without meeting catheter-specific criteria |
J-H (IN, MI) | WPS Government Health Administrators | 7.9 / 10 | Missing onset window for functional decline |
J-N (FL) | First Coast Service Options | 7.6 / 10 | High volume geriatric admissions; statistical outlier flagging |
Scribing.io's risk score dynamically adjusts the urgency and specificity of the N39.0 Guardrail prompt based on these patterns. A facility in J-E with a prior N39.0 denial in the trailing 12 months receives a more detailed, payer-specific prompt than a facility in a low-intensity jurisdiction with no denial history. This granularity prevents alert fatigue while maintaining audit defense where it matters most.
Implementation Workflow: Deploying the N39.0 Guardrail in Your Geriatric Service Line
Deployment follows a four-phase protocol designed to achieve measurable denial reduction within 60 days.
Phase 1: Baseline Audit (Days 1–14)
Scribing.io's implementation team conducts a retrospective analysis of your facility's N39.0 claims over the trailing 12 months. We identify:
Total N39.0 claims in patients ≥75
Percentage with ROS/lab contradictions
Percentage with functional decline documentation meeting the 4-element protocol
Historical denial and recoupment amounts
MAC jurisdiction and payer-specific risk exposure
Phase 2: EHR Integration (Days 15–30)
The N39.0 Guardrail integrates via FHIR R4 API (preferred) or HL7v2 ADT/ORU interfaces with Epic, Oracle Health, MEDITECH, and Athena. Integration includes:
LOINC feed normalization engine deployment
ROS field semantic mapping (custom to your facility's templates)
Assessment/Plan N39.0 detection rules
Catheterization status detection from nursing flowsheets
Prompt UI configuration (embedded in EHR workflow, not a separate window)
Phase 3: Clinician Training and Go-Live (Days 31–45)
Training is delivered in three 20-minute modules targeted to geriatric hospitalists, CDI specialists, and HIM coders separately. Each module focuses on the audience's specific workflow intersection with the Guardrail. Go-live includes a 14-day supervised monitoring period where Scribing.io's clinical team reviews every Guardrail interaction for calibration accuracy.
Phase 4: Outcomes Measurement (Days 46–60 and Ongoing)
Measurable outcomes tracked quarterly:
N39.0 denial rate (target: <5% from pre-implementation baseline)
ROS/lab contradiction rate (target: <2% of finalized notes)
ASB reclassification rate (expected: 15–25% of previously coded N39.0 cases)
Antibiotic stewardship alerts generated and actioned
Net revenue recovery vs. implementation cost
Protect Your Geriatric Revenue Line. Start With N39.0.
Every geriatric hospitalist program in the country is exposed to the N39.0 recoupment pattern described in this playbook. The EHR contradiction between auto-imported positive UA results and templated negative ROS entries is not a theoretical risk—it is happening in your charts today. The question is whether a CERT reviewer or RAC auditor finds it before you do.
Scribing.io eliminates the contradiction at the point of documentation, before the note is signed, before the claim is submitted, and before the auditor ever sees the chart. The N39.0 Guardrail is one component of a comprehensive clinical documentation integrity platform designed for the specific audit patterns targeting geriatric inpatient medicine.
Book a 15-minute demo to see the N39.0 Audit-Defense workflow in action: real-time ROS-contradiction detection, Loeb-aligned prompts, and payer-specific N39.0 risk scoring that runs inside your EHR. Schedule at Scribing.io →